Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
University College Hospital · University College London · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
530
total citations
- FWCI
- 49.19
- Percentile
- 100%
- References
- 64
Citations per year
Authors
31Topics & keywords
Topics
Keywords
- Seroconversion
- Medicine
- Vaccination
- Tolerability
- Pandemic
- Adverse effect
- Sore throat
- Viral load
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- GSGilead Sciences
- JHJohns Hopkins University
- LSLondon School of Hygiene and Tropical Medicine
- DFDepartment for Business, Energy and Industrial Strategy, UK Government
- URUK Research and InnovationAwards: MR/V028448, MR/V028448/1
- RFRoyal Free London NHS Foundation Trust
- NZNew Zealand Government
- NINational Institute for Health Research Health Protection Research UnitAwards: 200907, 200927
- NINational Institute for Health and Care ResearchAwards: BRC-1215-20008, IS-BRC-1215-20004, CO-CIN-01, NIHR201385, 200927, MR/V028448, award 200907, IS-BRC-1215, award 200927, NF-SI-0617-10010, MR/V028448/1, 200907, NIHR-BRC-1215-20008
- DODepartment of Health and Social Care
- ICImperial College LondonAward: 200927
- ICImperial College Healthcare NHS Trust
- UOUniversity of OxfordAward: 200907
- UOUniversity of Liverpool
- PHPublic Health EnglandAwards: 200907, 200927
- NINational Institute for Health Research Southampton Biomedical Research CentreAward: IS-BRC-1215-20004
- MRMedical Research CouncilAwards: 200907, MR/R015600/1, MR/V028448/1
- NINIHR Imperial Biomedical Research Centre
- NONIHR Oxford Biomedical Research CentreAwards: 1215-20008, NIHR-BRC-1215-20008, BRC-1215-20008
- NSNIHR Sheffield Biomedical Research Centre